Myelodysplastic syndromes trials in Estonia

1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

  Where

  Tallinn, Tartu Linn

  Age

  18 years to 75 years

  People

  650 worldwide

  Run by

  University of Ulm

  See details and how to joinNCT04628026 · EU 2023-507518-28-00